226
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Quantitative analysis of fetal DNA in maternal plasma in gestational diabetes mellitus, iron deficiency anemia and gestational hypertension pregnancies

, , , , &
Pages 960-966 | Received 06 Nov 2012, Accepted 10 Jan 2013, Published online: 20 Feb 2013

References

  • Mazza V, Pati M, Bertucci E, et al. Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases. Prenatal Diagnosis 2007;27:180–3
  • Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–7
  • Wataganara T, LeShane ES, Farina A, et al. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Human Genetics 2003;112:204–8
  • Sekizawa A, Jimbo M, Saito H, et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 2002;48:353–4
  • Sekizawa A, Sugito Y, Iwasaki M, et al. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin Chem 2001;47:2164–5
  • Zhong XY, Burk MR, Troeger C, et al. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenatal Diag 2000;20:795–8
  • Leung TN, Zhang J, Lau TK, et al. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998;352:1904–5
  • Helin A, Kinnunen TI, Raitanen J, et al. Reproductive medicine, obstetrics and gynaecology research: iron intake, haemoglobin and risk of gestational diabetes: a prospective cohort study. BMJ Open 2012;2:e001730. doi:10.1136/bmjopen-2012-001730
  • Schorr TO, Hediger ML. Anemia and iron-deficiency anemia: compilation of data on preganancy outcome. Am J Clin Nutr 1994;59:492S–501S
  • World Health Organization. Global Program to Conquer Preeclampsia/Eclampsia, 2002; PR WHO/44
  • Jekel JF, Katz DL, Elmore JG. Sample size, randomization, and probability theory. In: Jekel JF, Katz DL, Elmore JG, eds. Epidemiology, biostatistics, and preventive medicine. 2nd ed. Philadelphia: WB Saunders; 2001:197–212
  • Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768–75
  • Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, eds. Bioinformatics methods and protocols in the series methods in molecular biology. Totowa NJ: Humana Press; 2000:365–86
  • Pan PD, Peter I, Lambert-Messerlian GM, et al. Cell-free fetal DNA levels in pregnancies conceived by IVF. Hum Reprod 2005;20:3152–6
  • Ren CC, Miao XH, Cheng H, et al. Detection of Fetal sex in the peripheral blood of pregnant women. Fetal Diag Therapy 2007;22:377–82
  • Birch L, English CA, Donoghue K, et al. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 2005;51:312–20
  • Thilakavathy K, Essa JA, Rosli R. Fetal cell detection in minimal amount of maternal blood using HbF staining and polymerase chain reaction. Biomed Res 2002;13:5–10
  • Bianchi DW. Circulating fetal DNA: its origin and diagnostic potential-a review. Placenta 2004;25:93–101
  • Thilakavathy K, Rozita R, Baskaran TP. Exploring SOD1 gene for the detection of fetal down syndrome. J Prenatal Med 2008;2:36–9
  • Swinkels DW, de Kok JB, Hendriks JC, et al. Hemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002;48:650–3
  • Johnson KL, Dukes KA, Vidaver J, et al. Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem 2004;50:516–21
  • Scanlon KS, Yip R, Schieve LA, Cogswell ME. High and low hemoglobin levels during pregnancy: differential risks for preterm birth and small for gestational age. Am College Obstetr Gynecol: Anemia High Hemoglobin 2000;96:1–6
  • Baulon E, Fraser WD, Piedboeuf B, et al. Pregnancy-induced hypertension and infant growth at 28 and 42 days postpartum. BMC Pregnancy Childbirth 2000;5:14–20
  • Hiden U, Desoye G. Insulin and the placenta in GDM. In: Kim C, Ferrara A, eds. Gestational diabetes during and after pregnancy. London: Springer; 2010:97–111
  • Khozhai LI, Shishko TT, Kostkin VB, Otellin VA. Morphological changes in the fetal part of the allantoic placenta in rats exposed to acute hypoxia. Morfologiia 2007;32:61–4
  • Martinez-Frias ML, Bermejo E, Rodriguez-Pinilla E, et al. Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. Am J Med Genet 1998;78:140–5
  • Zhong XY, Holzgreve W, Hahn S. Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann NY Acad Sci 2001;945:138–40
  • Fournie GJ, Courtin JP, Laval F, et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995;91:221–7
  • Smith SC, Baker PN, Symonds EM. Placental apoptosis in normal human pregnancy. Am J Obstetr Gynecol 1997;177:57–65
  • Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447–51

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.